NasdaqGS:IRTCMedical Equipment
Did New Clinical Evidence for Zio Redefine iRhythm Technologies' (IRTC) Competitive Advantage in Cardiac Monitoring?
Earlier this month, iRhythm Technologies announced the publication of the AVALON study in the American Journal of Managed Care, showcasing the clinical superiority of its Zio long-term continuous monitoring service for arrhythmia detection among commercially insured adults.
This independent, real-world evidence study found that Zio offered the highest new arrhythmia diagnosis rate, faster time to diagnosis, reduced health care resource use, and lower total costs compared to competing cardiac...